BSF Enterprise Plc (LON:BSFA)
London · Delayed Price · Currency is GBP · Price in GBX 0.9100
-0.0400 (-4.21%)
Sep 25, 2026, 4:20 PM GMT
BSF Enterprise Market Cap
BSF Enterprise has a market cap or net worth of 1.82 million as of September 25, 2026. Its market cap has decreased by -46.43% in one year.
Market Cap
1.82M
Enterprise Value
2.54M
Revenue
51.07K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.91
ChartMarket Cap Chart
Since July 26, 2019, BSF Enterprise's market cap has increased from 1.02M to 1.82M, an increase of 79.21%. That is a compound annual growth rate of 8.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 1.82M | -25.28% |
| Dec 31, 2025 | 2.44M | -16.73% |
| Dec 31, 2024 | 2.93M | -72.34% |
| Dec 29, 2023 | 10.59M | -26.28% |
| Dec 30, 2022 | 14.37M | 841.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genflow Biosciences | 10.62M |
| Solvonis Therapeutics | 7.83M |
| CRISM Therapeutics | 7.72M |
| Cizzle Biotechnology Holdings | 7.01M |
| Thalia Therapeutics | 6.95M |
| OptiBiotix Health | 6.04M |
| Theracryf | 4.78M |
| Nuformix | 3.52M |